Show simple item record

dc.contributor.authorGow, Iain F.
dc.contributor.authorO'Donnell, M.
dc.contributor.authorO'Donnell, L.
dc.contributor.authorFlapan, A.
dc.date.accessioned2018-06-29T21:32:48Z
dc.date.available2018-06-29T21:32:48Z
dc.date.issued2011-12
dc.identifierER2558
dc.identifier.citationGow, I., O''Donnell, M., O''Donnell, L. & Flapan, A. (2011-12) Infusion of Mg in Humans Acutely Reduces Serum Insulin Levels: a Pilot Study, Magnesium Research, vol. 24, pp. 189-195.
dc.identifier.issn0953-1424
dc.identifier.urihttp://dx.doi.org/10.1684/mrh.2011.0295
dc.description.abstractBackground: infusion of Mg for therapeutic purposes is still a matter for debate. Dosages vary considerably, yet subclinical effects on normal physiology are largely ignored. In human and animal models, interactions between Mg and insulin exist, thus we have investigated the effect of infusing Mg on serum insulin, ionised Mg (Mg2+) and Ca (Ca2+) and plasma glucose in human volunteers. Methods: six male volunteers were infused with magnesium sulphate (MgSO4) dissolved in normal saline, using a high-dose loading- bolus, followed by a lower-level maintenance- period. Findings: serum Mg2+ rose rapidly throughout the bolus infusion, declined during the maintenance phase, but remained higher than pre-infusion levels throughout the experimental period; serum Ca2+ rose when serum Mg2+ was highest. Infusion of MgSO4 had no effect on heart rate or blood pressure, but caused a rapid, pronounced drop in circulating fasting insulin (p < 0.0005), which slowly recovered to basal values during the course of the maintenance infusion. A slight, transient rise in plasma glucose (p < 0.05) concomitant with the decline in serum insulin was also observed. Interpretation: it is possible that the effect of Mg2+ on insulin may have been due to antagonism of Ca2+ entry in pancreatic beta-cells, the insulin decline causing a subsequent rise in circulating glucose levels. We suggest that these effects of MgSO4 infusions should be considered where the aim is to achieve high doses of blood Mg2+ levels by clinical intervention.
dc.format.extent189-195
dc.publisherJohn Libbey Eurotext
dc.relation.ispartofMagnesium Research
dc.subjectMagnesium
dc.subjectIntravenous
dc.subjectInsulin
dc.subjectHuman
dc.titleInfusion of Mg in Humans Acutely Reduces Serum Insulin Levels: a Pilot Study
dc.typearticle
dcterms.accessRightspublic
dc.description.facultysch_die
dc.description.referencetext1 ISIS-4: ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 1995;345:669-685. 2 MAGIC Trial: Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial. Lancet 2002;360:1189-1196. 3 Muir KW, Lees KR, Ford I, Davis S: Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet 2004;363:439-445. 4 Wong GK, Poon WS, Chan MT, Boet R, Gin T, Ng SC, Zee BC: Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke 2010;41:921-926. 5 Rukshin V, Santos R, Gheorghiu M, Shah PK, Kar S, Padmanabhan S, Azarbal B, Tsang VT, Makkar R, Samuels B, Lepor N, Geft I, Tabak S, Khorsandhi M, Buchbinder N, Eigler N, Cercek B, Hodgson K, Kaul S: A prospective, nonrandomized, open-labeled pilot study investigating the use of magnesium in patients undergoing nonacute percutaneous coronary intervention with stent implantation. J Cardiovasc Pharmacol Ther 2003;8:193-200. 6 Tiryakioglu O, Demirtas S, Ari H, Tiryakioglu SK, Huysal K, Selimoglu O, Ozyazicioglu A: Magnesium sulphate and amiodarone prophylaxis for prevention of postoperative arrhythmia in coronary by-pass operations. J Cardiothorac Surg 2009;4:8. 7 Collaborative Eclampsia Trial: Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995;345:1455-1463. 8 How HY, Zafaranchi L, Stella CL, Recht K, Maxwell RA, Sibai BM, Spinnato JA: Tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: a randomized controlled pilot study. Am J Obstet Gynecol 2006;194:976-981. 9 Malaisse WJ, Devis G, Herchuelz A, Sener A, Somers G: Calcium antagonists and islet function. VIII. The effect of magnesium. Diabete Metab 1976;2:1-4. 10 Berggren PO, Bergsten P, Gylfe E, Larsson R, Hellman B: Interactions between magnesium and calcium in beta-cell-rich pancreatic islets. Am J Physiol 1983;244:E541-E547. 11 Vernon RG, Clegg RA, Flint DJ: Metabolism of sheep adipose tissue during pregnancy and lactation. Adaptation and regulation. Biochem J 1981;200:307-314. 12 Gow IF, Mitchell E, Wait M: Intravenous magnesium reduces the rate of glucose disposal in lactating sheep. Exp Physiol 2003;88:533-540. 13 Blendea MC, Orbai P, Dragotoiu G, Duncea I, Hazi G, Dumitru E, Gozariu L: Effects of parenteral pharmacological magnesium loading on insulin secretion in experimental thyrotoxicosis. Magnesium Research 1999;12:31-35. 14 Gow IF: Measurement of ionised magnesium in HEPES-buffered serum samples. Anal Chim Acta 2001;432:143-149. 15 Bergmeyer H: Reagents for enzymatic analysis; in Bergmeyer HU GK, (ed): Methods of Enzymatic Analysis. Weinheim, Verlag Chemie, 1974, pp 494-495. 16 Cholst IN, Steinberg SF, Tropper PJ, Fox HE, Segre GV, Bilezikian JP: The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med 1984;310:1221-1225. 17 Cruikshank DP, Pitkin RM, Reynolds WA, Williams GA, Hargis GK: Effects of magnesium sulfate treatment on perinatal calcium metabolism. I. Maternal and fetal responses. Am J Obstet Gynecol 1979;134:243-249. 18 Cruikshank DP, Pitkin RM, Donnelly E, Reynolds WA: Urinary magnesium, calcium, and phosphate excretion during magnesium sulfate infusion. Obstet Gynecol 1981;58:430-434. 19 Eisenbud E, LoBue CC: Hypocalcemia after therapeutic use of magnesium sulfate. Arch Intern Med 1976;136:688-691. 20 Gough IR, Balderson GA, Lloyd HM, Galligan J, Willgoss D, Fryar BG: The effect of intravenous magnesium sulphate on parathyroid function in primary hyperparathyroidism. World J Surg 1988;12:463-469. 21 Siggaard-Andersen O: Blood pH, carbon dioxide, oxygen, and calcium-ion; in Siggaard-Andersen O, (ed): Proceedings of the Fifth Meeting of the IFCC Expert Panel on pH and Blood Gases. Copenhagen, Private Press, 1981, p 163. 22 Kroll MH, Elin RJ: Relationships between magnesium and protein concentrations in serum. Clin Chem 1985;31:244-246. 23 Fogh-Andersen N, Bjerrum PJ, Siggaard-Andersen O: Ionic binding, net charge, and Donnan effect of human serum albumin as a function of pH. Clin Chem 1993;39:48-52. 24 Barbagallo M, Gupta RK, Bardicef O, Bardicef M, Resnick LM: Altered ionic effects of insulin in hypertension: role of basal ion levels in determining cellular responsiveness. J Clin Endocrinol Metab 1997;82:1761-1765. 25 Barbagallo M, Gupta RK, Resnick LM: Cellular ionic effects of insulin in normal human erythrocytes: a nuclear magnetic resonance study. Diabetologia 1993;36:146-149. 26 Curry DL, Bennett LL, Grodsky GM: Requirement for calcium ion in insulin secretion by the perfused rat pancreas. Am J Physiol 1968;214:174-178. 27 Iseri LT, French JH: Magnesium: nature's physiologic calcium blocker. Am Heart J 1984;108:188-193. 28 Devis G, Somers G, Van Obberghen E, Malaisse WJ: Calcium antagonists and islet function. I. Inhibition of insulin release by verapamil. Diabetes 1975;24:247-251. 29 Sambandam N, Abrahani MA, St PE, Al-Atar O, Cam MC, Rodrigues B: Localization of lipoprotein lipase in the diabetic heart: regulation by acute changes in insulin. Arterioscler Thromb Vasc Biol 1999;19:1526-1534. 30 Wolfe RR: Substrate utilization/insulin resistance in sepsis/trauma. Baillieres Clin Endocrinol Metab 1997;11:645-657. 31 Kohno H, Koyanagi T, Kasegawa H, Miyazaki M: Three-day magnesium administration prevents atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2005;79:117-126. 32 Haenni A, Johansson K, Lind L, Lithell H: Magnesium infusion improves endothelium-dependent vasodilation in the human forearm. Am J Hypertens 2002;15:10-15. 33 Apan A, Buyukkocak U, Ozcan S, Sari E, Basar H: Postoperative magnesium sulphate infusion reduces analgesic requirements in spinal anaesthesia. Eur J Anaesthesiol 2004;21:766-769. 34 Woods KL, Fletcher S: Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1994;343:816-819. 35 Ravn HB, Lassen JF, Bergenhem N, Kristensen AT: Intravenous magnesium does not influence the activity of the coagulation cascade. Blood Coagul Fibrinolysis 2001;12:223-228. 36 Falck G, Lundgaard H, Jareld T, Skarra S, Arbo I, Gunnes S, Jynge P: Effect of magnesium infusion on bleeding time in healthy male volunteers. Scand J Clin Lab Invest 1999;59:425-430. 37 Thwaites CL, Yen LM, Loan HT, Thuy TT, Thwaites GE, Stepniewska K, Soni N, White NJ, Farrar JJ: Magnesium sulphate for treatment of severe tetanus: a randomised controlled trial. Lancet 2006;368:1436-1443.
dc.description.volume24
dc.identifier.doi10.1684/mrh.2011.0295
dc.description.ispublishedpub
dc.description.eprintid2558
rioxxterms.typearticle
rioxxterms.publicationdate2011-12
qmu.authorGow, Iain F.
dc.description.statuspub
dc.description.number4


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record